German state minister visits JENETRIC to discuss biometrics and eGovernment initiatives
Thuringian Minister of Economic Affairs Wolfgang Tiefensee recently visited the JENETRIC GMBH office to discuss digitizing proof of identity with…
JENETRIC
JENETRIC
JENETRIC are experts in digital fingerprint capturing technology and develop and manufacture biometric scanners and sensors that meet the highest…
JENETRIC reports win in the Nail-to-Nail Fingerprint Challenge
JENETRIC today announced that it was recognized in the Nail-to-Nail fingerprint challenge for its approach to capture rolled fingerprints without…
Jenetric optical fingerprint device image quality certified by BSI
The German Federal Office for Information Security (BSI) has certified the high image quality of Jenetric’s Livetouch Quattro as meeting…
Jenetric introducing Livetouch Quattro Mobile at FedID 2017
Jenetric will be introducing its Livetouch Quattro Mobile handheld scanner at this week’s Federal Identity & Homeland Security exhibition in…
German Federal Police use Jenetric fingerprint solution to simplify border control
As part of the European Commission’s “Smart Borders” pilot project, the Frankfurt Main airport has been using Jenetric’s LIVETOUCH quattro…
Biometrics Research Group releases report on policing
Biometrics in policing will constitute half of the industry’s market share by the end of this decade, according to a…
German biometrics company Jenetric establishes office in the USA
Jenetric GmbH today announced the establishment of its wholly owned subsidiary Jenetric Inc., assuming the sales operations for American customers…
Jenetric receives ISO 9001 certification
German fingerprint scanner developer Jenetric GmbH announced that all of its departments are now ISO 9001 certified, including development, human resources,…
Jenetric looks to scale-up production, expand to US as it completes third funding round
German biometrics company Jenetric has completed a third investment round. The firms’ investors, High-Tech Gründerfonds and bm|t, confirmed their continued…
